Cargando…
Prevalence and Access of Secondary Source Medication Data: Evaluation of the Southeastern Diabetes Initiative (SEDI)
Medication non-adherence is a major public health issue, and measuring non-adherence is a crucial step toward improving it. A paucity of retrievable data prevents researchers from effectively measuring, tracking and sharing outcomes on medication management. High quality data derived from prescribin...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Informatics Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525251/ https://www.ncbi.nlm.nih.gov/pubmed/26306240 |
_version_ | 1782384301406420992 |
---|---|
author | Granger, Bradi B. Staton, Melodie Peterson, Lindsay Rusincovitch, Shelley A. |
author_facet | Granger, Bradi B. Staton, Melodie Peterson, Lindsay Rusincovitch, Shelley A. |
author_sort | Granger, Bradi B. |
collection | PubMed |
description | Medication non-adherence is a major public health issue, and measuring non-adherence is a crucial step toward improving it. A paucity of retrievable data prevents researchers from effectively measuring, tracking and sharing outcomes on medication management. High quality data derived from prescribing patterns, including behavioral and technology-based interventions, is necessary to support meaningful use, improve publicly reported quality metrics, and develop strategies to improve medication management. Electronic health records make medication data more numerous and accessible, yet the reliability and utility of electronically available data elements that reflect adherence has not been well established. We sought to explore the types of medication-related data captured over time in a series of patient encounters (n=5500) in a population-based intervention in four U.S. counties in the SouthEastern Diabetes Initiative (SEDI). The purpose was to evaluate data generated through routine healthcare delivery that are repurposed (ie, “secondary use”) for research/QI/population health. |
format | Online Article Text |
id | pubmed-4525251 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | American Medical Informatics Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-45252512015-08-24 Prevalence and Access of Secondary Source Medication Data: Evaluation of the Southeastern Diabetes Initiative (SEDI) Granger, Bradi B. Staton, Melodie Peterson, Lindsay Rusincovitch, Shelley A. AMIA Jt Summits Transl Sci Proc Articles Medication non-adherence is a major public health issue, and measuring non-adherence is a crucial step toward improving it. A paucity of retrievable data prevents researchers from effectively measuring, tracking and sharing outcomes on medication management. High quality data derived from prescribing patterns, including behavioral and technology-based interventions, is necessary to support meaningful use, improve publicly reported quality metrics, and develop strategies to improve medication management. Electronic health records make medication data more numerous and accessible, yet the reliability and utility of electronically available data elements that reflect adherence has not been well established. We sought to explore the types of medication-related data captured over time in a series of patient encounters (n=5500) in a population-based intervention in four U.S. counties in the SouthEastern Diabetes Initiative (SEDI). The purpose was to evaluate data generated through routine healthcare delivery that are repurposed (ie, “secondary use”) for research/QI/population health. American Medical Informatics Association 2015-03-25 /pmc/articles/PMC4525251/ /pubmed/26306240 Text en ©2015 AMIA - All rights reserved. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose |
spellingShingle | Articles Granger, Bradi B. Staton, Melodie Peterson, Lindsay Rusincovitch, Shelley A. Prevalence and Access of Secondary Source Medication Data: Evaluation of the Southeastern Diabetes Initiative (SEDI) |
title | Prevalence and Access of Secondary Source Medication Data: Evaluation of the Southeastern Diabetes Initiative (SEDI) |
title_full | Prevalence and Access of Secondary Source Medication Data: Evaluation of the Southeastern Diabetes Initiative (SEDI) |
title_fullStr | Prevalence and Access of Secondary Source Medication Data: Evaluation of the Southeastern Diabetes Initiative (SEDI) |
title_full_unstemmed | Prevalence and Access of Secondary Source Medication Data: Evaluation of the Southeastern Diabetes Initiative (SEDI) |
title_short | Prevalence and Access of Secondary Source Medication Data: Evaluation of the Southeastern Diabetes Initiative (SEDI) |
title_sort | prevalence and access of secondary source medication data: evaluation of the southeastern diabetes initiative (sedi) |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525251/ https://www.ncbi.nlm.nih.gov/pubmed/26306240 |
work_keys_str_mv | AT grangerbradib prevalenceandaccessofsecondarysourcemedicationdataevaluationofthesoutheasterndiabetesinitiativesedi AT statonmelodie prevalenceandaccessofsecondarysourcemedicationdataevaluationofthesoutheasterndiabetesinitiativesedi AT petersonlindsay prevalenceandaccessofsecondarysourcemedicationdataevaluationofthesoutheasterndiabetesinitiativesedi AT rusincovitchshelleya prevalenceandaccessofsecondarysourcemedicationdataevaluationofthesoutheasterndiabetesinitiativesedi |